PROTAGENIC THERAPEUTICS, INC.NEW (PTIX) financial statements (2021 and earlier)

Company profile

Business Address 149 FIFTH AVENUE
NEW YORK, NY 10010
State of Incorp. DE
Fiscal Year End December 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 3621,6853,10062101
Cash and cash equivalents 3624003,10062101
Short-term investments  1,286   
Prepaid expense 83956070144
Other undisclosed current assets 250    
Total current assets: 6961,7803,161132245
Noncurrent Assets
Property, plant and equipment 11111
Total noncurrent assets: 11111
TOTAL ASSETS: 6971,7813,162133246
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 232136168168141
Accounts payable     138
Accrued liabilities 101115  
Interest and dividends payable    213
Other undisclosed accounts payable and accrued liabilities 222125153147 
Derivative instruments and hedges, liabilities 676426517  
Other undisclosed current liabilities    21 
Total current liabilities: 908562685189141
Noncurrent Liabilities
Long-term debt and lease obligation    515175
Long-term debt, excluding current maturities    515175
Total noncurrent liabilities:    515175
Total liabilities: 908562685704316
Stockholders' equity
Stockholders' equity attributable to parent, including: (211)1,2192,477(497)(21)
Preferred stock    55
Common stock 111  
Additional paid in capital 13,35812,22811,2401,0531,053
Accumulated other comprehensive loss (171)(168)(182)  
Accumulated deficit (13,399)(10,842)(8,582)(1,555)(1,079)
Other undisclosed stockholders' equity attributable to parent 000  
Stockholders' equity attributable to noncontrolling interest    (74)(49)
Total stockholders' equity: (211)1,2192,477(571)(70)
TOTAL LIABILITIES AND EQUITY: 6971,7813,162133246

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
Gross profit: 3141  
Operating expenses (2,314)(2,365)(2,234)(491)(975)
Other undisclosed operating loss (3)(14)(1)  
Operating loss: (2,314)(2,365)(2,234)(491)(975)
Nonoperating income (expense) (243)106(42)(10)54
Foreign currency transaction loss, before tax   (7)  
Other nonoperating income    854
Interest and debt expense   (7)(18)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes   7  
Loss from continuing operations before equity method investments, income taxes: (2,558)(2,260)(2,276)(519)(924)
Other undisclosed income from continuing operations before income taxes    18 
Loss from continuing operations before income taxes: (2,558)(2,260)(2,276)(501)(924)
Income tax benefit    171604
Loss before gain (loss) on sale of properties: (2,558)(2,260)(2,276)(330)(320)
Other undisclosed net loss    (171)(808)
Net loss: (2,558)(2,260)(2,276)(501)(1,128)
Net income attributable to noncontrolling interest    2549
Net loss available to common stockholders, diluted: (2,558)(2,260)(2,276)(476)(1,079)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
Net loss: (2,558)(2,260)(2,276)(501)(1,128)
Other comprehensive loss (6)    
Comprehensive loss: (2,564)(2,260)(2,276)(501)(1,128)
Comprehensive income, net of tax, attributable to noncontrolling interest    2549
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 414(33)  
Comprehensive loss, net of tax, attributable to parent: (2,560)(2,246)(2,309)(476)(1,079)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: